Reta ZPHC (AQ pen) — 30 mg Premixed Pen

Scientific Name: Reta AQ Pen
Manufacturer: Zhengzhou Pharmaceutical (ZPHC)
Form: Premixed injectable pen (30 mg active compound)
Category: Hormonal/metabolic research compound
Mechanism: Provides a stable, ready‑to‑use formulation for precise dosing in metabolic and performance studies.

⚗️ Storage & Handling

• Store in a cool, dry place away from sunlight

• Refrigeration recommended for stability

• For research use only — not approved for human consumption outside supervised protocols
  
  

  Parameter	Standard Range	Notes
  Dose	2-6 mg per injection	Depends on study design and subject weight
  Frequency	1 time per week	Ensures steady compound availability
  Cycle Length	8-16 weeks	Often followed by equal off‑cycle period
  Administration	Subcutaneous or intramuscular injection	Pen allows precise, controlled delivery
  Timing	morning ( Fasted)	Mimics natural metabolic activity windows